We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$353M
AUM Growth
+$18.3M
Cap. Flow
+$4.78M
Cap. Flow %
1.35%
Top 10 Hldgs %
27.53%
Holding
115
New
5
Increased
40
Reduced
34
Closed
2

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$564K
2
CHRW icon
C.H. Robinson
CHRW
+$524K
3
GPI icon
Group 1 Automotive
GPI
+$236K
4
AAPL icon
Apple
AAPL
+$92.4K
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$86.8K

Sector Composition

Rank Sector Weight
1 Technology 14.43%
2 Healthcare 13.36%
3 Consumer Staples 11.59%
4 Industrials 10.86%
5 Consumer Discretionary 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHI icon
26
D.R. Horton
DHI
$40.7B
$5.04M 1.43%
41,444
-180
-0.4% -$19.7K
CMCSA icon
27
Comcast
CMCSA
$84B
$5M 1.42%
120,356
+251
+0.2% +$9.97K
XOM icon
28
ExxonMobil
XOM
$651B
$4.92M 1.39%
45,832
+650
+1% +$70.9K
IEMG icon
29
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$4.84M 1.37%
98,125
-735
-0.7% -$35.9K
CL icon
30
Colgate-Palmolive
CL
$73.3B
$4.74M 1.34%
61,506
+70
+0.1% +$5.42K
LMT icon
31
Lockheed Martin
LMT
$132B
$4.74M 1.34%
10,289
+53
+0.5% +$24.6K
OMC icon
32
Omnicom Group
OMC
$21.8B
$4.71M 1.33%
49,498
-10
-0% -$928
MDT icon
33
Medtronic
MDT
$110B
$4.67M 1.32%
53,000
+540
+1% +$46.5K
NEE icon
34
NextEra Energy
NEE
$183B
$4.66M 1.32%
62,815
+1,989
+3% +$151K
KO icon
35
Coca-Cola
KO
$381B
$4.64M 1.31%
77,070
-275
-0.4% -$17.1K
AMZN icon
36
Amazon
AMZN
$2.53T
$4.47M 1.27%
34,296
+725
+2% +$82.8K
CVS icon
37
CVS Health
CVS
$134B
$4.42M 1.25%
63,938
+2,106
+3% +$150K
IEFA icon
38
iShares Core MSCI EAFE ETF
IEFA
$192B
$4.37M 1.24%
64,750
-300
-0.5% -$20.3K
TMO icon
39
Thermo Fisher Scientific
TMO
$214B
$4.33M 1.23%
8,300
+117
+1% +$63.1K
SYY icon
40
Sysco
SYY
$40.6B
$4.16M 1.18%
56,035
+47,845
+584% +$3.54M
BNY
41
Bank of New York Mellon
BNY
$106B
$4.01M 1.14%
90,161
+1,821
+2% +$78.1K
INTC icon
42
Intel
INTC
$460B
$3.99M 1.13%
119,288
+540
+0.5% +$17K
IWM icon
43
iShares Russell 2000 ETF
IWM
$80.2B
$3.94M 1.12%
21,058
+35
+0.2% +$6.24K
XLE icon
44
State Street Energy Select Sector SPDR ETF
XLE
$39.2B
$3.75M 1.06%
92,482
+1,270
+1% +$51.7K
VZ icon
45
Verizon
VZ
$193B
$3.65M 1.03%
98,176
+4,915
+5% +$182K
DUK icon
46
Duke Energy
DUK
$98.4B
$3.58M 1.01%
39,860
+1,347
+3% +$127K
DIS icon
47
Walt Disney
DIS
$167B
$3.53M 1%
39,530
+1,979
+5% +$187K
SPY icon
48
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$3.21M 0.91%
7,230
-5
-0.1% -$2.1K
QRVO icon
49
Qorvo
QRVO
$8.01B
$3.08M 0.87%
30,216
-34
-0.1% -$3.26K
COP icon
50
ConocoPhillips
COP
$145B
$3M 0.85%
29,001
+882
+3% +$90.6K

Similar funds

Boston Research & Management's Q2 2023 Portfolio in Review

As of Q2 2023, Boston Research & Management held 115 positions worth $353M, up 5.5% from $335M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Boston Research & Management's Q2 2023 filing shows 5 new, 40 increased, 34 reduced and 2 closed positions. Its largest new stake was Masco: 4,000 shares worth $229K. The largest sale was Microsoft, an estimated $564K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Boston Research & Management's largest Q2 2023 buy was Masco: 4,000 shares worth $229K.
  • Boston Research & Management added most to Sysco in Q2 2023, an estimated $3.54M increase.
  • Boston Research & Management's biggest Q2 2023 reduction was Microsoft, cutting an estimated $564K.
  • Boston Research & Management fully exited C.H. Robinson in Q2 2023, selling an estimated $524K.
  • Boston Research & Management's ten largest holdings make up 28% of its $353M portfolio in Q2 2023.
  • Boston Research & Management opened 5 new positions and closed 2 in Q2 2023.
  • Boston Research & Management's portfolio value rose 5.5% quarter-over-quarter to $353M.

Based on Boston Research & Management's 13F filing for Q2 2023, filed 1 Aug 2023.